Optimization of chronomodulated delivery system coated with a blend of ethyl cellulose and Eudragit L100 by central composite design: In vitro and in vivo evaluation

Journal of Pharmaceutical Innovation

Volumn 9, Issue 2, 2014, Pages 95-105

  Ranjan, Om Prakash ^a   Nayak, Usha Y ^a   Reddy, M Sreenivasa ^a   Dengale, Swapnil J ^a   Musmade, Prashant B ^a   Udupa, Nayanabhirama ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Central composite design; Chronotherapy; Enteric polymer; Lag time; Pulsatile release

Indexed keywords

BUFFER; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; MONTELUKAST; POLYMER; SURFACTANT; TALC;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ASTHMA; BLOOD SAMPLING; CHRONOTHERAPY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DISSOLUTION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TABLET FORMULATION; TABLET SURFACE; WATER TRANSPORT;

EID: 84905740002     PISSN: 18725120     EISSN: 19398042     Source Type: Journal    
DOI: 10.1007/s12247-014-9176-3     Document Type: Article

References (13)

1. Fan TY, Wei SL, Yan WW, Chen DB, Li J. An investigation of pulsatile release tablets with ethylcellulose and Eudragit L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J Control Release. 2001;77:245-51. (Pubitemid 33145476)
2. Hao J, Wang F, Wang X, Zhang D, Bi Y, Gao Y, et al. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci. 2012;47:497-505.
3. Jha N, Bapat S. Chronobiology and chronotherapeutics. Kathmandu Univ Med J. 2004;2:384-8.
4. Lane SJ. Leukotriene antagonism in asthma and rhinitis. Respir Med. 1998;92:795-809. (Pubitemid 28360607)
5. Lecomte F, Siepmann J, Walther M, MacRae RJ, Bodmeier R. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns. J Control Release. 2003;89:457-71. (Pubitemid 36555904)
6. Nayak UY, Shavi GV, Nayak Y, Averinen RK, Mutalik S, Reddy SM, et al. Chronotherapeutic drug delivery for early morning surge in blood pressure: a programmable delivery system. J Control Release. 2009;136:125-31.
7. Nainwal N. Chronotherapeutics - a chronopharmaceutical approach to drug delivery in the treatment of asthma. J Control Release. 2012;163(3):353-60.
8. Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59:852-82. (Pubitemid 47542292)
9. Soni ML, Namdeo KP, Jain SK, Gupta M, Dangi JS, Kumar M, et al. pH-enzyme di-dependent chronotherapeutic drug delivery system of theophylline for nocturnal asthma. Chem Pharm Bull. 2011;59:191-5.
10. Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Azarmi S, Kobarfard F. Development and optimization of solid lipid nanoparticles of amikacin by central composite design. J Liposome Res. 2010;20:97-104.
11. Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377:185-98.
12. Yassin AE, Aodah AH, Al-Suwayeh S, Taha EI. Theophylline colon specific tablets for chronotherapeutic treatment of nocturnal asthma. Pharm Dev Technol. 2012;17:712-8.
13. Zhu Y, Zheng L. Development and mathematical simulation of theophylline pulsatile release tablets. Drug Dev Ind Pharm. 2005;31:1009-17. (Pubitemid 41759213)